|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
Q1 FY2023
As of Jun 30, 2022
|
Q4 FY2022
As of Mar 31, 2022
|
Q3 FY2022
As of Dec 31, 2021
|
Q2 FY2022
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Receivables (less allowance for doubtful accounts of $4,340 and $4,654, respectively) | ||||||||||||||||||||
| Inventories | ||||||||||||||||||||
| Total assets held-for-sale | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property, plant and equipment, net | ||||||||||||||||||||
| Other assets: | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| LIABILITIES, MEZZANINE EQUITY AND STOCKHOLDERS’ EQUITY | ||||||||||||||||||||
| Current liabilities: | ||||||||||||||||||||
| Current maturities of debt obligations | ||||||||||||||||||||
| Current maturities of finance lease obligations | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Total liabilities held-for-sale | ||||||||||||||||||||
| Other accrued liabilities | ||||||||||||||||||||
| Accrued income taxes | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term debt obligations (less unamortized debt issuance costs of $17,468 and $18,428, respectively) | ||||||||||||||||||||
| Long-term finance lease obligations | ||||||||||||||||||||
| Deferred tax liabilities | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Mezzanine equity: | ||||||||||||||||||||
| Redeemable common stock: $0.01 par value; 4,422 and 4,533 shares outstanding, respectively | ||||||||||||||||||||
| Total mezzanine equity | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Common stock; $0.01 par value: 1,000,000 shares authorized; 85,702 and 85,319 shares issued, respectively; 71,320 and 72,654 shares outstanding, respectively | ||||||||||||||||||||
| Paid-in capital | ||||||||||||||||||||
| Common stock in treasury, at cost | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Total ADS stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest in subsidiaries | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities, mezzanine equity and stockholders’ equity | ||||||||||||||||||||
Loading...